Lamivudine for chronic delta hepatitis

Hepatology

Volumn 30, Issue 2, 1999, Pages 546-549

  Lau, Daryl T Y ^a   Doo, Edward ^a   Park, Yoon ^b   Kleiner, David E ^c   Schmio, Peter ^d   Kuhns, Mary C ^e   Hoofnagle, Jay H ^a,f  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d National Genetics Institute   (United States)

^e ABBOTT LABORATORIES   (United States)

^f NIDDKNIH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DELTA AGENT HEPATITIS; DISEASE ACTIVITY; HUMAN; LIVER BIOPSY; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS REPLICATION;

ADULT; AGED; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0032765662     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300217     Document Type: Article

References (17)

1. Rizzetto M, Canese MG, Arico S, Crivelli O, Bonino F, Trepo CG, Verme G. Immunofluorescence detection of new antigen-antibody system (d/anti-d) associated to hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977;18:997-1003.
2. Taylor JM. Genetic organization and replication strategy of hepatitis delta virus. Semin Virol 1993;4:313-317.
3. Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Arico S, Calzia R, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen: an active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983;98:437-441.
4. Negro F, Rizzetto M. Diagnosis of hepatitis delta virus infection. J Hepatol 1995;22:136-139.
5. Thomas HC, Farci P, Shein R, Karayiannis P, Smedile A, Caruso L, Gerin J. Inhibition of hepatitis delta virus replication by lymphoblastoid human alpha interferon. Prog Clin Biol Res 1987;234:277-290.
6. Hoofnagle JH, Mullen K, Peters M, Avigan M, Park Y, Waggoner J, Gerin J, et al. Treatment of chronic delta hepatitis with recombinant human alpha interferon. Prog Clin Biol Res 1987;234:291-298.
7. Rosina F, Saracco G, Lattore V, Quartarone V, Rizzetto M, Verme G, Trinchero P, et al. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. Prog Clin Biol Res 1987;234:299-303.
8. Porres JC, Carreno V, Bartholome J, Moreno E, Galiana V, Quiroga JA. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses. J Hepatol 1989;9:338-350.
9. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12-month course of recombinant human interferon-α in chronic delta (type D) hepatitis: a multicenter Italian study. HEPATOLOGY 1991;13:1052-1056.
10. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330:88-94.
11. Di Marco V, Giacchino R, Timitilli A, Bortolotti F, Crivellaro C, Calzia R, lannuzzi C, et al. Long-term interferon-α treatment of children with chronic hepatitis delta: a multicenter study. J Viral Hepat 1996;3:123-128.
12. Hadziyannis SJ. Use of α-interferon in the treatment of chronic delta hepatitis. J Hepatol 1991;13:S21-S26.
13. Battegay M, Simpson LH, Hoofnagle JH, Sallie R, Di Bisceglie AM. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis. J Med Virol 1994;44:389-392.
14. Garripoli A, Di Marco V, Cozzolongo R, Costa C, Smedile A, Fabiano A, Bonino F, et al. Ribavirin for chronic hepatitis D: a pilot study. Liver 1994 Jun;14:154-157.
15. Arrigoni A, Ponzetto A, Actis G, Bonino E Levamisole and chronic delta hepatitis [Letter]. Ann Intern Med 1983;98:1024.
16. Cheng Y-C, Dutschman G, Fox JJ, Watanabe KA, Machida H. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob Agents Chemother 1981;20:420-423.
17. Tyrrell DLJ, Mitchell MC, De Man RA, Schalm SW, Main J, Thomas HC, Fevery J, et al. Phase II trial of lamivudine for chronic hepatitis B [Abstract]. HEPATOLOGY 1993;18:112A.